The American Society for Clinical Pharmacology and Therapeutics (ASCPT) seeks to have as its Governing Board a group of 11 leaders committed to the future of the field and the ASCPT mission to advance the science and profession. ASCPT seeks a board of accomplished clinical pharmacologists and translational scientists that represents diverse working environments (e.g., academic, regulatory, industry, and consulting), academic training, demographics, and geography. In addition, to serve its members and the field most effectively, ASCPT seeks a Board of accomplished and emerging scientists from a variety of clinical pharmacology and/or translational medicine disciplines.
Board Nominations have closed. Please check back for information about the 2019-2020 Board of Directors.
The following seats are available on the 2019-2020 ASCPT Board of Directors:
Two At-Large Board Members
- March 2019-2020 as President-Elect,
- March 2020-2021 as President, and
- March 2021-2022 as Past President.